News
$Centogene (CNTG.US)$ Centogene Announces Initial Data From ROPAD Study Showing 90% Of Genetically Confirmed Parkinson's Patients Have LRRK2 Or GBA1 Variants; Findings Indicate 15% Of PD Cases Linked To Genetic Variants; Data Published In Brain Journal Highlights Importance Of Genetic Testing In Gene-Targeted Trials
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
